What is the ticker symbol for Oculis Holding AG?

Oculis Holding AG trades under the ticker OCS on NASDAQ.

What sector does Oculis Holding AG operate in?

Oculis Holding AG is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze OCS in a portfolio?

PortView shows OCS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Oculis Holding AG (OCS) Stock Analysis

NASDAQHealthcareBiotechnology

$12.11-0.62%

1-year price historyRange $10.71 – $32.65

52-week range$12.11

$10.52$34.48

What Oculis Holding AG does

Oculis Holding AG is a biopharmaceutical company in the clinical development stage, specializing in the creation of innovative eye drop medications for various ocular conditions, addressing both the anterior and posterior segments of the eye. A key asset in its therapeutic portfolio is OCS-01, a topical formulation of dexamethasone, currently progressing through Phase 3 clinical trials for the management of diabetic macular edema. Additionally, OCS-02, a topically administered biological candidate, is engaged in Phase 2b clinical studies to treat keratoconjunctivitis sicca, commonly known as dry eye disease. The company is also advancing OCS-05, an innovative neuroprotective agent, which targets acute optic neuritis and an array of other neuro-ophthalmic disorders, including glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. This enterprise maintains its headquarters in Zug, Switzerland.

Key metrics

Market cap

$692.04M

P/E (TTM)

-6.96

EPS (TTM)

$-1.74

Beta

0.23

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$12.53

200-day avg

$21.15

52-week high

$34.48

52-week low

$10.52

CEO

Riad Sherif

ETFs linked to OCS

Broad-market and Healthcare sector ETFs an investor holding Oculis Holding AG is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how OCS fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze OCS in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Oculis Holding AG?: Oculis Holding AG trades under the ticker OCS on NASDAQ.
Which exchange is OCS listed on?: OCS is listed on NASDAQ.
What sector does Oculis Holding AG operate in?: Oculis Holding AG is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze OCS in a portfolio?: PortView shows OCS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.